PMID- 16536918 OWN - NLM STAT- MEDLINE DCOM- 20060425 LR - 20131121 IS - 0004-5632 (Print) IS - 0004-5632 (Linking) VI - 43 IP - Pt 2 DP - 2006 Mar TI - Plasma gastrin measurement cannot be used to diagnose a gastrinoma in patients on either proton pump inhibitors or histamine type-2 receptor antagonists. PG - 153-5 AB - BACKGROUND: Patients with a gastrinoma are treated with proton pump inhibitors (PPI) and histamine type-2 receptor antagonists (H2). In order to diagnose a gastrinoma these drugs must be discontinued, but this increases the risk of gastrointestinal perforation. We aimed to determine if a gastrinoma could be diagnosed without cessation of PPI/H2 therapy. METHODS: In all, 90 patients (controls and patients diagnosed with a gastrinoma both on and off PPI/H2 therapy) were recruited, and plasma gastrin measured. RESULTS: Patients with a gastrinoma on PPI/H2 medication had a significantly higher fasting plasma gastrin concentration than control patients on PPI/H2 medication (298+/-33 versus 204+/-30 pmol/L, P = 0.01). However, there was substantial overlap between gastrin levels in these two groups. CONCLUSION: This study confirms that a gastrinoma cannot be diagnosed on the basis of a fasting plasma gastrin assay while patients remain on PPI/H2 therapy. FAU - Dhillo, W S AU - Dhillo WS AD - Department of Endocrinology, Imperial College Faculty of Medicine, Hammersmith Hospital, London W12 ONN, UK. FAU - Jayasena, C N AU - Jayasena CN FAU - Lewis, C J AU - Lewis CJ FAU - Martin, N M AU - Martin NM FAU - Tang, K C N AU - Tang KC FAU - Meeran, K AU - Meeran K FAU - Todd, J F AU - Todd JF LA - eng GR - Wellcome Trust/United Kingdom PT - Comparative Study PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - England TA - Ann Clin Biochem JT - Annals of clinical biochemistry JID - 0324055 RN - 0 (Gastrins) RN - 0 (Histamine H2 Antagonists) RN - 0 (Proton Pump Inhibitors) SB - IM MH - Aged MH - Female MH - Gastrinoma/*diagnosis/drug therapy MH - Gastrins/*blood MH - Histamine H2 Antagonists/administration & dosage/*therapeutic use MH - Humans MH - Male MH - Middle Aged MH - Pancreatic Neoplasms/*diagnosis/drug therapy MH - *Proton Pump Inhibitors EDAT- 2006/03/16 09:00 MHDA- 2006/04/28 09:00 CRDT- 2006/03/16 09:00 PHST- 2006/03/16 09:00 [pubmed] PHST- 2006/04/28 09:00 [medline] PHST- 2006/03/16 09:00 [entrez] AID - 10.1258/000456306776021607 [doi] PST - ppublish SO - Ann Clin Biochem. 2006 Mar;43(Pt 2):153-5. doi: 10.1258/000456306776021607.